→ How This Was Created
She Built This Because Nothing in Her Own Lab Could Fix What Menopause Did to Her Eyes
Maya Chen spent eleven years as a senior formulation chemist at one of the world's largest beauty conglomerates. She worked on four of the top-ten bestselling eye creams in America. She held two patents in peptide delivery technology. She knew more about periorbital skincare than almost anyone on Earth.
And then she turned fifty-three.
Within eighteen months of her first hot flash, the skin under Maya's own eyes collapsed. Deep hollows appeared where there had been smoothness. Her upper lids began to hood over her lash line. The crepey texture was so pronounced she could see the veins underneath. She looked in the mirror every morning and didn't recognize the tired woman staring back.
So she did what any woman in her position would do: she raided her own lab. She applied every peptide serum she'd ever formulated. She stacked retinol, niacinamide, vitamin C, ceramides, caffeine. She got $400 NuFACE microcurrent sessions. She got $1,200 red-light mask treatments. She spent $600 on a single exosome facial at a clinic in Beverly Hills.
Nothing worked the way it was supposed to. Not at her age. Not on her skin. Not on the four forces that were happening under her eyes at the same time.
That's when Maya realized what thirty years in the beauty industry had taught her to ignore: eye creams were never designed to work. They were designed to sell. The real clinical technologies — EMS microcurrent, 630nm red light, exosome-peptide delivery — existed, but they lived in dermatologist offices and cost $5,000 a year to access. The beauty counter was selling her $220 jars of water while the actual answer was locked inside her own doctor's clinic.
So Maya quit. She cashed out her 401(k). She spent the next four years in a lab in San Diego with a team of two engineers and three board-certified dermatologists, miniaturizing the three clinical technologies into a single silver pen that a fifty-eight-year-old woman could use in ninety seconds while she brushed her teeth.
Within six months of launch, the first batch sold out. Then the second. Then the third. Today, over three hundred thousand AMPI pens have shipped. More than eleven thousand women have left five-star reviews. Every applicator is still manufactured in the same FDA-registered facility Maya chose on day one. Every formula is still third-party tested, cruelty-free, and backed by a 60-day money-back guarantee — because Maya would never sell something she wouldn't stake her own reputation on.
"Every eye cream on the market is trying to scream through a wall. My exosomes don't break through the wall. They have a key."
— Maya Chen, Founder of AMPI
This is exactly why women spend $220 on Augustinus Bader, $200 on La Mer Eye Concentrate, $98 on SkinCeuticals A.G.E. Eye Complex — and still see zero lift, zero firmness, zero change in their hooded lids. The ingredients were never the problem. The delivery was. The device was. The three technologies nobody was combining were.
Every single one of those creams addresses one of the four forces, at best. AMPI is the first product to address all four — because a woman who'd spent her entire career formulating eye creams finally admitted they weren't enough.
CHECK AVAILABILITY →